Jessica Albert
Associate Director
Biochemical GeneticsĂ‚Â
Kennedy Krieger Institute
United States of America
Biography
Jessica Albert has done PhD and works as a Associate Director. Biographical sketch: Dr. Albert received her bachelors of science from University of Maryland, College Park in 2007, and her doctorate in Molecular Medicine from the University of Maryland at Baltimore in 2012. She completed a post-doctoral fellowship and clinical fellowship in biochemical genetics at The National Institutes of Health in 2014, and completed a clinical fellowship in molecular genetics in 2016. In 2015, Dr. Albert became board certified in biochemical genetics. She has been with the Kennedy Krieger Institute since 2014. Dr. Albert is a member of the Society for Inherited Metabolic Disorders. Research Summary: Dr. Albert’s interests focus on the diagnosis of inborn errors of metabolism and clinical research related to these disorders. One area of interest involves disorders of cholesterol biosynthesis including Smith-Lemli-Opitz syndrome, Desmosterolosis, and X-Linked Dominant Conradi Hünermann Syndrome. Another area of interest includes metabolism of citric acid cycle intermediates and how disturbances in the cycle lead to mitochondrial disease.
Research Interest
Biochemical Genetics
Publications
-
"1. Weeks HM, Therrien AS, Bastian AJ. The cerebellum contributes to proprioception during motion. J Neurophysiol (2017). 2. Roemmich RT, Long AW, Bastian AJ Seeing the Errors You Feel Enhances Locomotor Performance but Not Learning. Curr Biol (2016). 3. Bar H, Mentch L R-CMap-An open-source software for concept mapping. Eval Program Plann (2016). 4. Weeks HM, Therrien AS, Bastian AJ Proprioceptive Localization Deficits in People With Cerebellar Damage. Cerebellum (2016).
-
"1. Albert JS, Bhattacharyya N, Wolfe LA, Bone WP, Maduro V, Accardi J. Impaired osteoblast and osteoclast function characterize the osteoporosis of Snyder - Robinson syndrome. Orphanet J Rare Dis (2015) 10: 27. 2. Kratz LE, Albert JS 2-Ethylhexanoic acid, found in common plasticizers, leads to an artificial increase in C8 acylcarnitine levels in two neonates treated with extracorporeal membrane oxygenation (ECMO). Clin Chim Acta (2016) 461: 59-60. 3. Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med (2014) 370: 2307-2315.
